Suche

zurück zur Zentren Übersicht

Bayern

LMU - Klinikum der Universität München - Institut für Klinische Neuroimmunologie

Marchioninistr. 15
D-81377 München

Leitung: Prof. Dr. Martin Kerschensteiner

Studien

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Studien

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)